Authors: PORTIER H MAY T PROUST A TOLSTUCHOW N MUIR JF BALMES P",PAGANIN,"CARLES P BLANCHON F ROCHEMAURE J TONNEL AB DUMONT P WALLAERT C RAGNAUD JM BECQGIRAUDON B NOUVET G WEITZENBLUM E LENG B GAILLAT J DEFOUILLOY C ARNAUD A HERER B MIECH G MODAI J CREPIN JL BERNARD P CORDIER JF BART F CLAVIER J STAHL JP POLU JM LACROIX S JEANNIN L BENOIT JP BALGARIES JL BARBIEUX H BEYTOUT J PARIENTE R PATEY O RAFFI F TUCHAIS E SERGEANT YH CHOUTET P CAILLAUX D

Citation: H. Portier et al., COMPARATIVE EFFICACY OF SPARFLOXACIN IN COMPARISON WITH AMOXICILLIN PLUS OFLOXACIN IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA, Journal of antimicrobial chemotherapy, 37, 1996, pp. 83-91

Authors: BARJHOUX C PEPIN JL DESCHAUXBLANC C KULPA M CORNETTE A DESRUES B GIRAULT C GAUZERE B BEDICAM JM GREIL A FOURNIAL F HUMEAU MP MIECH G ARTAUD M BEHR L PONCEY C SAUTEGEAU A VERGERET J BRAMBILLA C

Citation: C. Barjhoux et al., LONG-TERM OXYGEN-THERAPY - COMPLIANCE WIT H PRESCRIBED OXYGEN FOR AT LEAST 15 HOURS PER DAY, Revue des maladies respiratoires, 11(1), 1994, pp. 37-45

Authors: DEPIERRE A MILLERON B LEBEAU B MORO D CHASTANG C JACOULET P PAILLOT N QUOIX E JANICOT H LOMBARD JN GOUVA S BRECHOT JM LEMARIE E MIECH G BRETON JL COETMEUR D

Citation: A. Depierre et al., AN ONGOING RANDOMIZED STUDY OF NEOADJUVANT CHEMOTHERAPY IN RESECTABLENONSMALL CELL LUNG-CANCER, Seminars in oncology, 21(3), 1994, pp. 16-19